Neo Ivy Capital Management Cytokinetics Inc Transaction History

Neo Ivy Capital Management

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 29, 2023	BUY	$29.46 - $36.61 $469,710 - $583,709	15,944 New	15,944 $470,000
Q2 2022 Aug 16, 2022	SELL	$33.93 - $48.92 $169,378 - $244,208	-4,992 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$29.74 - $46.0 $74,468 - $115,184	-2,504 Reduced 33.4%	4,992 $184,000
Q4 2021 Feb 15, 2022	BUY	$34.35 - $46.38 $257,487 - $347,664	7,496 New	7,496 $341,000

410

125M

4.6M

2.43M

Ticker CYTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,144,096
Market Cap $4.92B
Description
Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...

Get notified when there are updates to the investment portfolio of Neo Ivy Capital Management, based on Form 13F filings with the SEC.

Stay updated on Neo Ivy Capital Management with notifications on news.